Bruker (BRKR)
(Delayed Data from NSDQ)
$75.71 USD
-0.50 (-0.66%)
Updated May 10, 2024 04:00 PM ET
After-Market: $75.73 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Price, Consensus and EPS Surprise
BRKR 75.71 -0.50(-0.66%)
Will BRKR be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for BRKR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BRKR
Down -22.53% in 4 Weeks, Here's Why Bruker (BRKR) Looks Ripe for a Turnaround
Bruker (BRKR) Q1 Earnings Surpass Estimates, Margins Decline
BRKR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bruker (BRKR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Are Computer and Technology Stocks Lagging Alphabet (GOOGL) This Year?
Bruker (BRKR) Q1 Earnings Beat Estimates
Other News for BRKR
Bruker’s Legal Victories and NanoString Acquisition Bolster Buy Rating
Shhh! 3 Secret Nanotech Stocks Flying Below Wall Street’s Radar
Bruker Corporation to Host Investor Webinar on May 17, 2024
German Federal Patent Court Invalidates Patent Asserted By 10x Genomics, Delivering Legal Win to NanoString and Bruker
10x Genomics stock slides amid German patent court ruling